Upcoming Events
Fourth Quarter and Full Year Results 2020 and Annual Report 2020 publication
Jan 26, 2021
Basel, Switzerland
Watch the webcast
14:00 CET - 13:00 GMT - 08:00 EST
Annual General Meeting
Mar 02, 2021
Basel, Switzerland
Event Calendar
View recent presentations and learn more about upcoming events.
Recent Events
J.P. Morgan Healthcare Conference
Jan 11, 2021
Virtual / San Francisco, USA
Co-Creating Impact Summit
Société Générale Premium Review Conference
Dec 02, 2020
Virtual / Paris, France
Berenberg European Conference
Dec 02, 2020
Virtual / London, UK
Redburn CEO Conference
Dec 01, 2020
Virtual / London, UK
Meet Novartis Management
UBS European Conference
Nov 11, 2020
London, UK
Inaugural Healthcare CEO Summit
Nov 05, 2020
Baltimore, USA
Webinar: Measuring and evaluating social outcomes of access initiatives
Oct 28, 2020
Third quarter results 2020
Bank of America Merrill Lynch Global Healthcare Conference
Sep 18, 2020
London, UK
Novartis ESG Investor Event
Kesimpta® FDA Approval Investor Call
Aug 21, 2020
Basel, Switzerland
ESG materiality assessment webinar: Wealth and Health - Reframing healthcare costs as economic investments
Jul 30, 2020
Second quarter results 2020
ESG materiality assessment webinar: Embracing double materiality in responding to the COVID-19 pandemic
Jun 25, 2020
JP Morgan European Healthcare Conference
Jun 18, 2020
London, UK
Citi European Healthcare Conference
Jun 17, 2020
London, UK
Oncology Pipeline Update
Jun 15, 2020
Basel, Switzerland
ESG materiality assessment webinar: sickle cell disease
May 28, 2020
UBS Virtual Global Healthcare Conference
May 19-20, 2020
First quarter results 2020
Zolgensma® MDA Data Investor Call
Mar 30, 2020
Basel, Switzerland
Bernstein DCAT
Mar 25, 2020
New York, USA
Cowen Healthcare Conference
Mar 04, 2019
Boston, USA
Annual General Meeting
Feb 28, 2020
Basel, Switzerland
Leerink Global Healthcare Conference
Feb 27, 2020
New York, USA
Guggenheim Healthcare Talks
Feb 13, 2020
New York, USA
Fourth Quarter and Full Year Results 2019 and Annual Report 2019 publication
Jan 29, 2020
Basel, Switzerland
Media release:
Condensed financial report (PDF 0.6 MB)
Read the presentation transcript
Download the podcast (MP3 43 MB)
Download the presentation (PDF 3.6 MB)
J.P. Morgan Healthcare Conference
2019 Archive
Citi Healthcare Conference
Dec 11, 2019
New York, USA
R&D Day
Berenberg European Corporate Conference
Dec 04, 2019
London, UK
Novartis enters into agreement to acquire The Medicines Company
Jefferies London Healthcare Conference
Nov 20, 2019
London, UK
UBS European Conference
Nov 12, 2019
London, UK
Wolfe Healthcare Conference
Nov 06, 2019
New York, USA
ZKB Swiss Conference
Nov 06, 2019
Zurich, Switzerland
Third quarter results 2019
Oct 22, 2019
Basel, Switzerland
Beovu® FDA Approval
Oct 08, 2019
Basel, Switzerland
Kisqali® MONALEESA-3 ESMO Data Investor Call
Oct 01, 2019
Basel, Switzerland
Bernstein’s Strategic Decisions Conference
Sep 26, 2019
London, UK
Baader Investment Conference
Sep 24, 2019
Munich, Germany
Bank of America Merrill Lynch Global Healthcare Conference
Sep 18, 2019
London, UK
Ofatumumab (OMB157) ECTRIMS Data Investor Call
Sep 16, 2019
Basel, Switzerland
ESG Investor Event
UBS Best of Switzerland Conference 2019
Sep 05-06, 2019
Zurich, Switzerland
Zolgensma® Update
Second quarter results 2019
July 18, 2019
Basel, Switzerland
JP Morgan European Healthcare Conference
Jun 20, 2019
London, UK
Citi European Healthcare Conference
Jun 19, 2019
London, UK
Wolfe Research Pipelines Unplugged
Jun 05, 2019
New York, USA
Vontobel Summer Conference
Jun 05, 2019
Interlaken, Switzerland
Jefferies Global Healthcare Conference
Jun 04, 2019
New York, USA
ASCO Investor Event
Jun 02, 2019
Chicago, USA
UBS Best of Europe Conference
May 29, 2019
New York, USA
Zolgensma® and Piqray® US FDA Approvals
Meet Novartis Management investor event in Boston
May 23, 2019
Boston, USA
Novartis enters into agreement to acquire Xiidra®
Zolgensma AAN Data Investor Call
May 08, 2019
Philadelphia, USA
First quarter results 2019
Apr 24, 2019
Basel, Switzerland
2017/2018 Results for Continuing Operations
Apr 24, 2019
Mayzent FDA Approval Investor Call
Mar 27, 2019
Basel, Switzerland
Updated Alcon 20-F filed with the SEC
Mar 22, 2019
Kepler Cheuvreux Swiss Seminar
Mar 21, 2019
Zurich, Switzerland
Bernstein DCAT Day
Mar 18, 2019
New York, USA
Barclays Global Healthcare Conference
Mar 12, 2019
Miami, USA
Cowen Healthcare Conference
Mar 11, 2019
Boston, USA
Credit Suisse Global Healthcare Conference
Mar 06, 2019
London, UK
Leerink Global Healthcare Conference
Mar 01, 2019
New York, USA
Annual General Meeting
Feb 28, 2019
Basel, Switzerland
Citi's 7th Annual IO Leadership Summit
Feb 19, 2019
New York, USA
Guggenheim Partners Oncology Day
Feb 14, 2019
New York, USA
Fourth Quarter and Full Year Results 2018 and Annual Report 2018 publication
J.P. Morgan Healthcare Conference
Jan 07, 2019
San Francisco, USA
2018 Archive
Citi Healthcare Conference
Dec 05, 2018
New York, USA
Berenberg European Corporate Conference
Dec 05, 2018
London, UK
Alcon capital markets day in London
Dec 04, 2018
London, UK
Alcon capital markets day in New York
Nov 27, 2018
New York, USA
Jefferies London Healthcare Conference
Nov 14, 2018
London, UK
UBS European Conference
Nov 13, 2018
London, UK
SG European ESG/SRI Conference Paris
Nov 13, 2018
Paris, France
Credit Suisse Healthcare Conference
Nov 12-13, 2018
Phoenix, USA
HSBC Healthcare Day
Nov 12, 2018
Frankfurt, Germany
Morningstar's Management Behind the Moat Conference
Nov 07-08, 2018
Chicago, USA
Restatement for the Innovative Medicines and Alcon Segments 2015 and 2016 following the OTC Transfer
Nov 07, 2018
Novartis R&D update
Nov 05, 2018
London, UK
ESMO Investor Call
Third quarter results 2018
Oct 18, 2018
Basel, Switzerland
Media release
Interim financial report (PDF 0.7 MB)
Read the presentation transcript
Bernstein’s Strategic Decisions Conference
Sep 26, 2018
London, UK
Novartis ESG conference call
Sep 17, 2018
Basel, Switzerland
Bank of America Merrill Lynch Global Healthcare Conference
Sep 13, 2018
London, UK
Morgan Stanley Conference
Sep 12-13, 2018
New York, USA
UBS Best of Switzerland Conference 2018
Sep 06-07, 2018
Zurich, Switzerland
Wells Fargo Healthcare Conference
Sep 05, 2018
Boston, USA
Second quarter results 2018
Jul 18, 2018
Basel, Switzerland
Media release
Interim financial report (PDF 0.5 MB)
Novartis concludes strategic review of Alcon and initiates share buyback
Jun 29, 2018
Download the presentation (PDF 1.2 MB)
Download the podcast (MP3 17 MB)
Read the media release:
JP Morgan European Healthcare Conference
Jun 21, 2018
London, UK
Citi European Healthcare Conference
Jun 20, 2018
London, UK
Barclays European Select Conference
Jun 13-15, 2018
Sonoma, USA
Morgan Stanley Digital Health Day
Jun 13, 2018
London, UK
Goldman Sachs Global Healthcare Conference
Jun 11-12, 2018
Los Angeles, USA
Jefferies Global Healthcare Conference
Jun 06, 2018
New York, USA
Vontobel Summer Conference
Jun 05-06, 2018
Interlaken, Switzerland
Novartis Oncology ASCO Investor Event
Jun 03, 2018
Chicago, USA
UBS Best of Europe Conference
May 31, 2018
New York, USA
Bernstein Pipelines Unplugged
May 22, 2018
UBS Global Healthcare Conference
May 21, 2018
New York, USA
Aimovig™ US FDA Approval
May 18, 2018
Visit the Amgen website
Novartis and Amgen jointly promote Aimovig™ in the US
Meet Novartis Management investor event in Basel
First quarter results 2018
Novartis Enters into Agreement to Acquire AveXis
Apr 09, 2018
08:00 CEST – Investor call 1
18:00 CEST – Investor call 2
Media Release
Download the presentation (PDF 0.6 MB)
Novartis 2017 Financials – Updated Segment Reporting
Apr 03, 2018
Kepler Cheuvreux Swiss Seminar
Mar 23, 2018
Zurich, Switzerland
Oppenheimer Healthcare Conference
Mar 21, 2018
New York, USA
Barclays Global Healthcare Conference
Mar 14, 2018
Miami, USA
Cowen Healthcare Conference
Mar 12-13, 2018
Boston, USA
Annual General Meeting
Mar 02, 2018
Basel, Switzerland
BTIG Healthcare Conference
Feb 27, 2018
Snowbird, USA
Credit Suisse Global Healthcare Conference
Feb 27, 2018
London, UK
Leerink Healthcare Conference
Feb 15, 2018
New York, USA
Fourth quarter and full year results 2017 and Annual Report 2017 publication
Jan 24, 2018
Basel, Switzerland
Media release
Condensed financial report (PDF 0.5 MB)
J.P. Morgan Healthcare Conference
Jan 08, 2018
San Francisco, USA
Paul Hudson
Chief Executive Officer of Novartis Pharmaceuticals
Disclaimer:
Disclaimer: The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
Contact Investor Relations
Investors International:
Call +41 61 324 79 44
Investors North America:
Call +1 862 778 5052
Novartis Share Registry:
For information relating to the registration of your shares, including name or address changes, please contact us by e‑mail or telephone:
Call +41 61 324 72 04